The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Camrelizumab combined with paclitaxel and nedaplatin as neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma (ESPRIT): A phase II, single-arm, exploratory research.
 
Jianqun Ma
No Relationships to Disclose
 
Yingnan Yang
No Relationships to Disclose
 
Jinfeng Zhang
No Relationships to Disclose
 
Hongxue Meng
No Relationships to Disclose
 
Xiaodong Ling
No Relationships to Disclose
 
Xiaoyuan Wang
No Relationships to Disclose
 
Yanzhong Xin
No Relationships to Disclose
 
Hao Jiang
No Relationships to Disclose
 
Luquan Zhang
No Relationships to Disclose
 
Chengyuan Fang
No Relationships to Disclose
 
Hao Liang
No Relationships to Disclose
 
Jinhong Zhu
No Relationships to Disclose
 
Xionghai Qin
No Relationships to Disclose
 
Jingle Lei
No Relationships to Disclose